CVRx President and CEO Nadim Yared Named Chairman of the MDIC Board of Directors
MDIC announced today that CVRx’s President and CEO Nadim Yared has been named chairman of the MDIC Board of Directors and Executive Committee for a two-year term. Yared has served on the MDIC Board of Directors since 2013. He will succeed Abiomed President and CEO, Michael Minogue who will remain on the Board. Read the […]
MDIC Releases 2018 Annual Report
MDIC is excited to announce the release of our first annual report and share the impact of our work during the 2018 year. This report not only helps quantify and demonstrate the impact we’ve had but also helps us identify opportunities for growth and improvement. Some of the key highlights from the Annual Report include […]
NESTcc Announces 12 New Real-World Evidence Test Cases
Today, NESTcc announced 12 new Real-World Evidence (RWE) Test-Cases. These projects will answer questions of importance to the medical device ecosystem through collaborations between NESTcc Network Collaborators and submitting organizations, including health systems, government organizations, non-profit patient organizations, and medical device manufacturers. NESTcc’s Test-Case portfolio now includes 20 projects that span the Total Project Life […]
MDIC Seeks Comments on Draft List of Prioritized Tumor Suppressors
MDIC’s Clinical Diagnostics Cancer Genomic Somatic Reference Samples working group seeks public comments on the draft list of prioritized tumor suppressors. The goal of the initiative is to develop reference samples that can be made available to the public to improve the accuracy, reliability and transparency of Next-Generation-Sequencing (NGS) based oncology tests. In addition, the […]
MDIC Holds External Evidence Methods Executive & Fellows Meeting
On April 2, 2019, MDIC’s External Evidence Methods (EEM) program hosted an Executive & Fellows meeting with about 70 subject matter experts from FDA, industry, and non-profit organizations to discuss the existing methods and identify gaps for the use of external data. MDIC’s EEM program aims to establish a more predictable pathway for use of external […]
MDIC Releases RFI on Creating Human Cell Lines
MDIC released a Request for Information (RFI) on March 30, 2019. We are requesting technical information about available and possible approaches for creating a set of human cell lines that include all–or subsets of– specific variants. The variants were drawn from a larger list developed by the MDIC SRS working group and include clinically actionable […]
MDIC to Release RFI on Creating Human Cell Lines
MDIC will release a Request for Information (RFI) on March 30, 2019. We are requesting technical information about available and possible approaches for creating a set of human cell lines that include all–or subsets of– specific variants. The variants were drawn from a larger list developed by the MDIC SRS working group and include clinically […]
MDIC Releases Catalog of Known SRS Products for NGS-based Oncology Tests
On March 6, 2019, MDIC released a Landscape Analysis report compiling all the currently available somatic variant reference samples for next-generation sequencing-based tests. This report, researched and assembled by MDIC’s Somatic Reference Samples Landscape Analysis working group, is a catalog of known SRS products for NGS-based oncology tests compiled in one resource, according to the […]
MDIC Blood Damage Working Group to present at BMES/FDA Frontiers in Medical Devices Conference
Dr. Marc Horner, MDIC’s Blood Damage Modeling Working Group Chair, will discuss the Blood Damage Modeling project updates and future directions at the BMES/FDA Frontiers in Medical Devices Conference: The Role of Digital Evidence to Support Personalized Patient Healthcare on March 19-21, 2019 at the College Park Marriott Hotel and Conference Center at the University of Maryland. […]
